---
filename: neurologic-emergencies-status-epilepticus-and-stroke.md
id: neurologic-emergencies-status-epilepticus-and-stroke
title: Neurologic Emergencies (Status Epilepticus & Stroke)
slug: neurologic-emergencies-status-epilepticus-and-stroke
tags: [neurology, inpatient, night-float, emergencies]
level: resident
estimated_time_min: 18
version: 2026-02-20
source: IM_NightFloat_Engine
---

# Neurologic Emergencies (Status Epilepticus & Stroke)

## Panic Card
- Airway, breathing, circulation; check **FSBG now**; give **thiamine 100 mg IV before dextrose** if malnourished risk; place on cardiorespiratory and end‑tidal CO₂ monitoring. citeturn2search50
- Ongoing seizures ≥5 min: give **lorazepam 0.1 mg/kg IV (max 4 mg)** or **midazolam 10 mg IM** immediately; repeat once in 5 min if needed. citeturn2search50turn2search22
- Suspected acute ischemic stroke: determine **Last Known Well**; get **noncontrast head CT**; aim **door‑to‑imaging ≤20 min**; consider **IV alteplase ≤4.5 h** or **mechanical thrombectomy up to 24 h in selected LVO**. **Confirm Before Proceed:** thrombolysis contraindications reviewed. citeturn2search2turn2search4
- Before IV thrombolysis, lower **BP <185/110 mmHg** (e.g., labetalol, nicardipine); after treatment, maintain **<180/105 mmHg for 24 h**. citeturn2search2
- If hemorrhage on CT: reverse anticoagulants per agent; target **SBP ~140–160 mmHg** promptly; call neurosurgery/neuro‑ICU. **Confirm Before Proceed:** reversal products and doses verified. citeturn2search13

## Brief Overview
- **Guideline Must‑Know:** Status epilepticus (SE) is ≥5 min of continuous seizures or recurrent seizures without recovery; treat in parallel with ABCs and early benzodiazepines to prevent refractoriness. citeturn2search50
- **Guideline Must‑Know:** First‑line for convulsive SE: **lorazepam 0.1 mg/kg IV (max 4 mg)**, **midazolam 10 mg IM** if no IV, or **diazepam 10 mg IV**; repeat once if needed. Avoid under‑dosing. citeturn2search22turn2search24
- **Guideline Must‑Know:** If seizures persist, proceed immediately to urgent control therapy with one of: **levetiracetam 60 mg/kg IV (max 4.5 g)**, **fosphenytoin 20 mg PE/kg IV**, or **valproate 40 mg/kg IV**. Choose based on comorbidities and interactions. citeturn2search50
- **Guideline Must‑Know:** Refractory SE (persistent after a benzodiazepine + a second agent): start anesthetic infusion (e.g., **midazolam** or **propofol**) titrated to seizure suppression/burst‑suppression with continuous EEG if available; consider transfer if cEEG unavailable. citeturn2search52
- Evaluate precipitating causes alongside treatment: **FSBG**, electrolytes, tox, AED levels, infection workup; obtain **noncontrast head CT**; consider LP only after stabilization. citeturn2search50
- Avoid rapid correction of chronic hyponatremia; enforce **Na⁺ correction ≤8–10 mmol/L per 24 h** (≤4–6 if high risk). citeturn2search38
- **Guideline Must‑Know:** Stroke: for suspected acute ischemic stroke (AIS), determine **Last Known Well** precisely and activate imaging and telestroke pathways; **NCCT** is first‑line to exclude bleed; CTA ± perfusion for LVO selection. citeturn2search2
- **Guideline Must‑Know:** IV thrombolysis should begin **as quickly as possible within ≤4.5 h** when eligible. **Alteplase 0.9 mg/kg (max 90 mg)** is standard; **tenecteplase 0.25 mg/kg (max 25 mg)** is an acceptable alternative in selected patients per recent AHA/ASA update. **Confirm Before Proceed** thrombolysis contraindications. citeturn2search2turn2search3
- **Guideline Must‑Know:** Endovascular therapy for anterior‑circulation LVO is recommended **≤6 h** and **reasonable up to 24 h** in selected patients (DAWN/DEFUSE 3 criteria or equivalent perfusion mismatch). Escalate to neurointerventional team early. citeturn2search4
- BP management in AIS: prior to IVT, **<185/110**; after IVT **<180/105**; avoid aggressive post‑EVT hypotension. In ICH, lower **SBP to ~140–160** promptly while avoiding large variability. citeturn2search2turn2search17
- Antiplatelets: if no IVT, initiate **aspirin within 24 h**; if minor non‑cardioembolic stroke/TIA within 24 h, consider **short DAPT** per prevention guidance (defer if IVT given). Escalate to neurology for nuances. citeturn2search30
- **Guideline Must‑Know:** For anticoagulated patients (e.g., DOAC within 48 h and normal renal function), **IV thrombolysis is generally contraindicated**; if LVO and otherwise eligible, **proceed to EVT**; discuss reversal only when indicated and beneficial. citeturn2search2
- **Guideline Must‑Know:** ICH care: rapidly reverse warfarin with **4‑factor PCC**, dabigatran with **idarucizumab**, factor Xa inhibitors with **andexanet alfa** when appropriate; avoid routine platelet transfusions unless emergent surgery/severe thrombocytopenia. citeturn2search17
- Night pitfalls: missing nonconvulsive SE post‑stopping convulsions (need cEEG if persistent encephalopathy), undertreating benzodiazepine doses, delaying CTA/perfusion for potential EVT candidates, or forgetting to re‑measure BP targets after IVT/EVT. citeturn2search50turn2search2
- **Guideline Must‑Know:** Oxygenation/ventilation: treat hypoxemia, avoid hyperoxia; protect airway in ongoing convulsions; consider early intubation for RSE or aspiration risk; maintain **MAP ≥65 mmHg** if shock occurs and follow pressor hierarchy. citeturn2search38
- **Guideline Must‑Know:** Document clearly: timing (LKW), NIHSS, contraindication screen, consent/risk discussion for thrombolysis/EVT, post‑treatment neuro checks, BP/bleed monitoring; for SE, total doses/timing and EEG findings. citeturn2search31

## Top ICU/Consult Triggers
- Persistent seizures despite benzodiazepine plus one second‑line agent, or need for anesthetic infusion/cEEG (refractory SE). citeturn2search52
- AIS with **LVO**, large infarct risk/mass effect, declining mental status, or **NIHSS high** requiring EVT or neuro‑ICU monitoring. citeturn2search4
- ICH, SAH suspicion, or post‑thrombolysis deterioration (new headache, emesis, acute HTN, neuro decline). citeturn2search13
- Airway compromise, **SpO₂ <90%**, aspiration, or hemodynamic instability/shock. citeturn2search38

## Orders to Place Now
- Order: CT head without contrast — {stat, stroke_protocol=yes, include_time_last_known_well} citeturn2search2
- Order: CTA head/neck ± CT perfusion — {if LVO suspected or late window; renal_function={Cr,eGFR}} citeturn2search4
- Order: Alteplase IV for AIS — {weight_kg, total_dose=0.9 mg/kg max 90 mg, bolus=10%, infusion=90% over 60 min, BP_goal=<180/105} citeturn2search2
- Order: Tenecteplase IV push for AIS (if appropriate) — {dose=0.25 mg/kg max 25 mg, single bolus, BP_goal=<180/105} citeturn2search3
- Order: Benzodiazepine for SE — {lorazepam 0.1 mg/kg IV max 4 mg OR midazolam 10 mg IM if no IV access} citeturn2search22turn2search50
- Order: Urgent control antiseizure med — {choose one: levetiracetam 60 mg/kg IV max 4.5 g OR fosphenytoin 20 mg PE/kg IV OR valproate 40 mg/kg IV} citeturn2search50

## ABIM‑Style Question 1

### Stem
A 68‑year‑old with hypertension presents 90 minutes after sudden aphasia and right hemiparesis. BP is 198/112 mmHg, glucose 110 mg/dL, NIHSS 14. Noncontrast CT shows no hemorrhage. CTA is not yet done.

### Options
A. Give IV alteplase now without further delay  
B. Lower BP to **<185/110 mmHg** with IV labetalol, then give IV alteplase  
C. Wait for CTA and perfusion imaging before deciding on thrombolysis  
D. Start aspirin 325 mg now and plan dual antiplatelet therapy  
E. Give tenecteplase 0.25 mg/kg now without addressing BP

### Correct answer
B

### Rationale
IV thrombolysis should be administered within **≤4.5 h** in eligible patients, but **BP must be <185/110 mmHg before** treatment and maintained **<180/105** after; antihypertensive therapy (e.g., labetalol) should precede alteplase. Delaying for advanced imaging (CTA/perfusion) is not required to start IVT when NCCT excludes hemorrhage. Tenecteplase is reasonable in selected patients per updated guidance but still requires BP control. citeturn2search2turn2search4turn2search3

## Second ABIM‑Style Case (Pitfall Variant)

### Stem
A 72‑year‑old with atrial fibrillation (on apixaban; last dose 3 hours ago) presents 2 hours after LKW with left MCA syndrome, NIHSS 16. BP 172/98 mmHg. NCCT shows no hemorrhage. CTA shows a proximal left M1 occlusion.

### Options
A. Give IV alteplase because within 4.5 h  
B. Give tenecteplase 0.25 mg/kg because it is easier to administer  
C. Proceed directly to mechanical thrombectomy; withhold IV thrombolysis  
D. Reverse apixaban with andexanet alfa, then give IV alteplase  
E. Start heparin infusion while awaiting interventional team

### Correct answer
C

### Rationale
Recent DOAC ingestion is a **contraindication to IV thrombolysis** in most cases; this patient has an LVO and is an EVT candidate, so proceed to thrombectomy without IVT. Reversal solely to enable thrombolysis is not routine in AIS and should be individualized; anticoagulation is not indicated acutely. The pitfall is giving thrombolysis despite **recent DOAC use**. citeturn2search2

What changed the decision here?

## Check‑Yourself Micro‑Questions
- Q: What lorazepam dose is recommended first‑line for adult convulsive SE?  
  A: **0.1 mg/kg IV (max 4 mg)**; repeat once in 5 minutes if needed.
- Q: What BP must be achieved before IV thrombolysis for AIS?  
  A: **<185/110 mmHg** before IVT; then **<180/105 mmHg** for 24 h after.
- Q: What is the extended window for EVT in select anterior circulation LVO strokes?  
  A: Up to **24 hours** from LKW if advanced imaging shows salvageable tissue.
- Q: List one standard second‑line agent and dose for established SE.  
  A: **Levetiracetam 60 mg/kg IV (max 4.5 g)**; alternatives are fosphenytoin or valproate.
- Q: What sodium correction limit prevents osmotic demyelination in hyponatremia?  
  A: **≤8–10 mmol/L per 24 h** (≤4–6 if high risk).

## Guidelines & Key References
- AHA/ASA. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines. [Slide deck PDF] citeturn2search2
- AHA/ASA. Acute Ischemic Stroke Guideline — published in Stroke, January 26, 2026 (publication schedule notice). [Professional Heart Daily] citeturn2search26
- AHA/ASA. Guidelines for Managing Patients With Acute Ischemic Stroke: Key Summary (late window EVT up to 24 h). [AIS toolkit PDF] citeturn2search4
- Neurocritical Care Society. ENLS 6.0 Status Epilepticus Protocol (July 2024). [PDF] citeturn2search50
- American Epilepsy Society. Evidence‑Based Guideline: Treatment of Convulsive Status Epilepticus (2016). [PDF] citeturn2search22
- AHA/ASA. 2022 Guideline for Management of Spontaneous Intracerebral Hemorrhage (clinical update slides). [PDF] citeturn2search13
- JAMA Medical News. 2026 AHA/ASA AIS guideline highlights (tenecteplase option). citeturn2search3

## CDI: What to Document Clearly Tonight
- Acute ischemic stroke due to presumed large‑vessel thromboembolism — onset (LKW), NIHSS, territory, candidacy/decision for IVT/EVT, contraindication screen, BP targets, objective imaging/labs, treatment given (dose/time), complications monitoring.
- Status epilepticus — convulsive vs nonconvulsive, etiology (e.g., metabolic/toxic/structural), total antiseizure doses/timing, response, airway/vent support, cEEG findings.
- Hypertensive emergency secondary to stroke — severity, end‑organ effects (neuro deficits, imaging), agents/doses to achieve **SBP/BP goals**, monitoring plan.
- Anticoagulation status — agent, last dose/time, renal function, reversal decision/rationale, risks/benefits discussion documented.
- Aspiration risk or pneumonia due to neurologic deficit — evidence (CXR/fever/leukocytosis), type (aspiration), severity, treatment and need for NPO/SLP evaluation.
